Back to Search
Start Over
Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment.
- Source :
-
Journal of affective disorders [J Affect Disord] 2019 Jun 01; Vol. 252, pp. 25-31. Date of Electronic Publication: 2019 Apr 03. - Publication Year :
- 2019
-
Abstract
- Background: Major depressive disorder (MDD) is a heterogeneous condition. Identifying the brain responses to antidepressant treatment is of particular interest as these may represent potential neural networks related to treatment response, forming one aspect of the biological markers of MDD. Near-infrared spectroscopy (NIRS) is suitable for repeated measurements with short intervals because of its noninvasiveness, and can provide detailed time courses of functional alterations in prefrontal regions.<br />Methods: We conducted a 12-week longitudinal study to explore prefrontal hemodynamic changes at 4-week intervals following sertraline treatment in 11 medication-naïve participants with MDD using 52-channel NIRS.<br />Results: While all participants achieved remission after treatment, intra-class correlation coefficient of oxygenated hemoglobin [oxy-Hb] values throughout the 12-week observation was moderate at the spatially and temporally contiguous cluster located in the left inferior frontal and temporal gyri. There was a significant negative correlation between mean [oxy-Hb] values in the significant cluster at 4 weeks and changes in Hamilton Rating Scale for Depression total score from 4 to 8 weeks (r = -0.73, P = 0.011) and from 4 to 12 weeks (r = -0.63, P = 0.039).<br />Limitations: Without healthy controls for comparison, we were unable to fully evaluate whether improvement of [oxy-Hb] activations after treatment in MDD reached normal levels or not.<br />Conclusion: Our NIRS findings of detailed prefrontal hemodynamic alterations over short interval observations such as 4 weeks may have revealed potential trait marker for MDD and biological maker for predicting clinical response to sertraline treatment in MDD.<br /> (Copyright © 2019. Published by Elsevier B.V.)
- Subjects :
- Adult
Antidepressive Agents pharmacology
Antidepressive Agents therapeutic use
Depressive Disorder, Major drug therapy
Female
Humans
Longitudinal Studies
Male
Oxyhemoglobins metabolism
Psychiatric Status Rating Scales
Sertraline therapeutic use
Spectroscopy, Near-Infrared
Time Factors
Treatment Outcome
Young Adult
Depressive Disorder, Major metabolism
Hemodynamics drug effects
Prefrontal Cortex blood supply
Sertraline pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1573-2517
- Volume :
- 252
- Database :
- MEDLINE
- Journal :
- Journal of affective disorders
- Publication Type :
- Academic Journal
- Accession number :
- 30959413
- Full Text :
- https://doi.org/10.1016/j.jad.2019.04.001